bromocriptine mesylate

Generic: bromocriptine mesylate

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bromocriptine mesylate
Generic Name bromocriptine mesylate
Labeler zydus lifesciences limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

bromocriptine mesylate 5 mg/1

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 65841-654
Product ID 65841-654_f9589272-83ad-497b-8a10-42ff73384d25
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078899
Listing Expiration 2026-12-31
Marketing Start 2009-01-23

Pharmacologic Class

Classes
ergolines [cs] ergot derivative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65841654
Hyphenated Format 65841-654

Supplemental Identifiers

RxCUI
197412
UNII
FFP983J3OD

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bromocriptine mesylate (source: ndc)
Generic Name bromocriptine mesylate (source: ndc)
Application Number ANDA078899 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (65841-654-01)
  • 30 CAPSULE in 1 BOTTLE (65841-654-06)
source: ndc

Packages (2)

65841-654-01 100 CAPSULE in 1 BOTTLE (65841-654-01) 65841-654-06 30 CAPSULE in 1 BOTTLE (65841-654-06)

Ingredients (1)

bromocriptine mesylate (5 mg/1)

Linked Drug Pages (1)

Bromocriptine mesylate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f9589272-83ad-497b-8a10-42ff73384d25", "openfda": {"unii": ["FFP983J3OD"], "rxcui": ["197412"], "spl_set_id": ["97e7e051-ff64-4381-a869-6c1c364ad822"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (65841-654-01)", "package_ndc": "65841-654-01", "marketing_start_date": "20090123"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (65841-654-06)", "package_ndc": "65841-654-06", "marketing_start_date": "20090123"}], "brand_name": "Bromocriptine mesylate", "product_id": "65841-654_f9589272-83ad-497b-8a10-42ff73384d25", "dosage_form": "CAPSULE", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "65841-654", "generic_name": "Bromocriptine mesylate", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bromocriptine mesylate", "active_ingredients": [{"name": "BROMOCRIPTINE MESYLATE", "strength": "5 mg/1"}], "application_number": "ANDA078899", "marketing_category": "ANDA", "marketing_start_date": "20090123", "listing_expiration_date": "20261231"}